Form D · Biotechnology
Luna Genetics, Inc.
Houston, TX · CIK 0001813501
Offering snapshot reported Dec 29, 2022 · SEC filing
- Reported sold
- $2.94M Offering amount: $3M
- Investors reported
- 10 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Dec 20, 2022 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Dec 29, 2022 | Initial | $2,940,000 | No comparison | 10 | SEC filing |
| Apr 25, 2022 | Initial | $4,875,000 | No comparison | 26 | SEC filing |
| Dec 15, 2021 | Initial | $665,010 | No comparison | 6 | SEC filing |
| Mar 23, 2021 | Initial | $2,365,000 | No comparison | 19 | SEC filing |
| May 29, 2020 | Initial | $1,212,461 | No comparison | 11 | SEC filing |
Offering details
- Securities
- Debt, Option to acquire
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-469027
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| Chardan Capital Markets LLC | 120128 |
Source: Form D, filed Dec 29, 2022. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Arthur L. Beaudet | Director, Executive |
| Michael F. Mc Manus | Executive |
| Philip Reilly | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
2575 West Bellfort
Houston, TX, 77054
Houston, TX, 77054